Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia- reperfusion injury

Journal of Surgical Research

Volumn 69, Issue 2, 1997, Pages 425-428

  Engles, Robert E ^a   Huber, Thomas S ^a   Zander, Dani S ^a   Hess, Philip J ^a   Welborn, M Burress ^a   Moldawer, Lyle L ^a   Seeger, James M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATTENUATION; CAPILLARY PERMEABILITY; CELL DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; HINDLIMB; ISCHEMIA; LUNG INJURY; MALE; MUSCLE INJURY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SOLEUS MUSCLE;

EID: 0031148074     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5109     Document Type: Conference Paper

References (30)

1. 1. Hess, P. J., Seeger, J. M., Huber, T. S., Welborn, M. B., Martin, T. D., Harward, T. R. S., Duschek, S., Edwards, P. D., Solorzano, C. C., Copeland, E. M., and Moldawer, L. L. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a TNF-dependent murine model of acute visceral ischemia. J. Vasc. Surg., in press.
2. 2. Cassatella, M. A., Meda, L., Bonora, S., Ceska, M., and Constantin, G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178: 2207, 1993.
3. 3. Kasama, T., Strieter, R. M., Lukacs, N. W., Burdick, M. D., and Kunkel, S. L. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol. 152: 3559, 1994.
4. 4. Wang, P., Wu, P., Anthes, J. C., Siegel, M. I., Egan, R. W., and Billan, M. M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83: 2678, 1994.
5. 5. Gruber, M. F., Williams, C. C., and Gerrard, T. L. Macrophage-colony-stimulating factor expression by anti-CD45 stimulated human monocytes is transcriptionally up-regulated by IL-1 beta and inhibited by IL-4 and IL-10. J. Immunol. 152: 1354, 1994.
6. 6. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209, 1991.
7. 7. Jenkins, J. K., Malyak, M., and Arend, W. P. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1-beta production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13: 84, 1994.
8. 8. Sternbergh, III W. C., Tuttle, M. D., Makhoul, R. G., Bear, H. D., Sobel, M., and Fowler, A. A. Postischemic extremities exhibit immediate release of tumor necrosis factor. J. Vasc. Surg. 20: 474, 1994.
9. 9. Seekamp, A., Warren, J. S., Remick, D. G., Till, G. O., and Ward, P. A. Requirements for tumor necrosis factor-α and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am. J. Pathol 143: 453, 1993.
10. 10. Blebea, J., Kerr, J. C., Franco, C. D., Padberg, F. T., and Hobson, R. W. Technetium 99m pyrophosphate quantitation of skeletal muscle ischemia and reperfusion injury. J. Vasc. Surg. 8: 117, 1988.
11. 11. Welborn, M. B., Douglas, W. G., and Abouhamze, Z., et al. Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse. Shock 6: 171, 1996.
12. 12. Espevik, T., and Nissen Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95: 99, 1968.
13. 13. Eppinger, M. J., Deeb, G. M., Boiling, S. F., and Ward, P. A. Regulatory role of IL-10 in rat lung ischemia-reperfusion injury. Surg. Forum, 306, 1995.
14. 14. Cavaillon, J. M. Cytokines and macrophages. Biomed-Pharmacother. 48: 445, 1994.
15. 15. Hart, P. H., Jones, C. A., and Finlay-Jones, J. J. Monocytes cultured in cytokine-defined environements differ from freshly isolated monocytes in their responses to IL-4 and Il-10. J. Leukocyte Biol. 57: 909, 1995.
16. 16. Perretti, M., Szabo, C., and Thiemermann, C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production the mouse. Br. J. Pharmacol. 116: 2251, 1995.
17. 17. Huhn, R. D., Radwanski, E., O'Conell, S. M., Sturgill, M. G., Clark, L., Cody, R. P., Affrime, M. B., and Cutler, D. L. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 87: 699, 1996.
18. 18. Harward, T. R. S., Martin, T. D., Welborn, M. B., Oldenberg, H. S. A., Douglas, W., Espat, N. J., Moldawer, L. L., Copeland, E. M., and Seeger, J. M. Tumor necrosis factor - α (TNF-α), interleukin-1β (IL-1β), and interleukin-8 (IL-8) are released following thoracoabdominal aneurysm repair and TNF-α levels are related to patient outcome. Surg. Forum, 18, 1995.
19. 19. Harward, T. R. S., Welborn, M. B., Martin, T. D., Flynn, T. C., Huber, T. S., Moldawer, L. L., and Seeger, J. M. Visceral ischemia and organ dysfunction after thoracoabdominal aneurysm repair. Ann. Surg. 223: 729, 1996.
20. 20. Donnelly, S. C., Strieter, R. M., Reid, P. T., Kunkel, S. L., Burdick, Armstrong, I., Mackenzie, A., and Haslett, C. The association between mortality rates and decreased concentrations of inter leukin-10 and interleukin-1 receptor antagonist in the lung fields of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 125: 191, 1996.
21. 21. Gomez-Jimenez, J., Martin, M. C., Sauri, R., Segura, R. M., Esteban, F., Ruiz, J. C., Nuvials, X., Boveda, J. L., Peracaula, R., and Salgado, A. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J. Infect. Dis. 171: 472, 1995.
22. 22. Lehmann, A. K., Halstensen, A., Sornes, S., Rokke, O., and Waage, A. High levels of interleukin-10 in serum are associated with fatality in meningococcal disease. Infect. Immun. 63:2109, 1995.
23. 23. Greenberger, M. J., Strieter, R. M., Kunkel, S. L., Danforth, J. M., Goodman, R. E., and Standiford, T. J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155: 722, 1995.
24. 24. de Vries, J. E. Immunosuppressive and anti-inflammatory properties of interleukin-10. Ann. Med. 27: 537, 1995.
25. 25. Schreiber, S., Heinig, T., Heinz-Gunther, T., et al. Immunoregulatory role of interleukin-10 in inflammatory bowel disease. Gastroenterology, in press.
26. 26. Kuhn, R., Lohier, J., Rennick, D., et al. Interleukin 10 deficient mice develop chronic enterocolitis. Cell 75: 263, 1993.
27. 27. Schreiber, S., Heinig, T., Heinz-Gunther, T., et al. Immunoregulatory role of interleukin-10 in inflammatory bowel disease. Gastroenterology 108: 1434, 1995.
28. 28. Katsikis, P., Chu, C. Q., Brennan, F. M., et al. Immunoregulatory role of IL-10 in rheumatoid arthritis. J. Exp. Med. 179: 1517, 1994.
29. 29. Van den Verg, W. V., Joosten, L. A. B., Jacobs, M., et al., Suppression of established collagen-induced arthritis with IL-4 and Il-10. Arthritis Rheum. 37: S280, 1994.
30. 30. Williams, O., Feldmann, M., and Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89: 9784, 1992.